Chronic wounds resist treatment in part because it is difficult to deliver sustained, local immune signals that guide repair. Cytokines are key signaling proteins for inflammation and healing, but they often degrade quickly and do not stay at the wound site long enough to be effective. To overcome this limitation, Rice University researchers developed a living bandage that produces therapeutic cytokines at the wound over time; the study appears in Nature Biomedical Engineering.
The patch contains encapsulated ARPE-19 cells engineered to secrete cytokines such as IL-10, IL-12 and TGF-β. These cells sit inside a biocompatible hydrogel matrix that permits nutrients and proteins to pass through while protecting the cells from the host immune system. Because the platform is modular, the engineered cells can be swapped to produce different cytokines, growth factors or other therapeutic proteins as needed.
Preclinical tests in murine and porcine excisional wound models showed accelerated healing. RNA sequencing and transcriptomic analysis revealed coordinated upregulation of genes linked to tissue regeneration and immune modulation, providing a likely molecular mechanism for the improved repair. The researchers note the platform could be combined with bioelectronic components and that future work will explore real‑time control of cytokine release, for example by optogenetic methods. The research received support from the Defense Advanced Research Projects Agency; press materials are the responsibility of the authors. Source: Rice University.
- Encapsulated ARPE-19 cells engineered to secrete IL-10, IL-12 and TGF-β
- Biocompatible hydrogel matrix that permits exchange but shields cells
- Modular design adaptable for different therapeutic proteins
Difficult words
- cytokine — signaling proteins that control inflammation and healingcytokines
- hydrogel — soft water-based material that supports living cellshydrogel matrix
- encapsulate — to surround cells with a protective layerEncapsulated
- modular — designed in parts that can be changed
- transcriptomic — study of all RNA molecules made in cells
- optogenetic — controlling cells or proteins using light
- biocompatible — safe for living tissue or organisms
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- What advantages and risks can you see for a living bandage that produces cytokines at a wound site? Give reasons.
- How could a modular design for the engineered cells change treatment options for different types of wounds? Give examples.
- What safety, ethical or regulatory issues should researchers consider before using engineered cell patches in people?
Related articles
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.
Calorie restriction improves muscle insulin response in old rats
In 24-month-old rats, eating 35% less for eight weeks changed many muscle proteins and improved insulin-stimulated glucose uptake. Males and females showed different molecular responses, and two proteins may be targets for diabetes treatment.
Gaps in Measles Knowledge and Vaccination in Emergency Departments
A University of California, Riverside study found important gaps in measles knowledge and MMR vaccination among emergency department patients. Researchers reported hesitancy and disparities linked to race, language, insurance and access to primary care.